Lysosomal Storage Disease Treatment Market Share

Market Share of Lysosomal Storage Disease Treatment Industry

The lysosomal storage disease treatment market is consolidated and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. Some of the leading market players include Pfizer Inc, Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi (Genzyme Corporation), BioMarin, Johnson & Johnson (Actelion Pharmaceuticals Ltd), Amicus Therapeutics, Inc, Alexion Pharmaceuticals, Inc, Sigilon Therapeutics, Inc and Orphazyme A/S.

Lysosomal Storage Disease Treatment Market Leaders

1. Pfizer Inc

2. Takeda Pharmaceutical Company Limited (Shire Plc)

3. Sanofi (Genzyme Corporation)

4. BioMarin

5. Johnson & Johnson (Actelion Pharmaceuticals Ltd)

*Disclaimer: Major Players sorted in no particular order